XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM
Report
- Report Number
- 2024168-2010-02406
- Event Type
- Injury
- Date Received
- November 10, 2010
- Date of Event
- May 25, 2010
- Report Date
- October 20, 2010
- Manufacturer
- ABBOTT VASCULAR-CARDIAC THERAPIES
- Product Code
- NIQ
- PMA / PMN Number
- P070015
- Removal / Correction Number
- NA
- Adverse Event
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- PA, US
- Reporter Occupation
- PHYSICIAN
Narratives
(B)(4). THE STENT REMAINS IN THE PT. ANGINA, MYOCARDIAL INFARCTION (MR), AND RESTENOSIS ARE KNOWN ADVERSE EVENTS AS LISTED IN THE XIENCE V INSTRUCTIONS FOR USE. ALTHOUGH A CONCLUSIVE CAUSE FOR THE REPORTED PT EFFECTS AND THE RELATIONSHIP TO THE DEVICE, IF ANY, COULD NOT BE DETERMINED,THERE IS NO INDICATION OF A PRODUCT QUALITY DEFICIENCY WITH RESPECT TO MANUFACTURER OR DESIGN.
IT WAS REPORTED VIA A TRAIL THAT ON (B)(6) 2008, THE PT UNDERWENT STENTING IN THE PREDILATED MID RIGHT CORONARY ARTERY WITH ONE XIENCE V STENT. ON (B)(6) 2010, THE PT EXPERIENCED EARLY MORNING CHEST PAIN OF MODERATE INTENSITY. THE PT TOOK SUBLINGUAL NITROGLYCERIN AND PHONED THE AMBULANCE. THE ELECTROCARDIOGRAM SHOWED A Q WAVE AND ST ELEVATION MYOCARDIAL INFARCTION. THE PT WAS HOSPITALIZED AND UNDERWENT PERCUTANEOUS CORONARY REVASCULARIZATION ON (B)(6) 2010 IN THE TARGET LESION AND IN THE NON-TARGET PROXIMAL LEFT CIRCUMFLEX ARTERY. THE PATIENT'S CONDITION RESOLVED AND WAS DISCHARGED ON (B)(6) 2010. THOUGH REQUESTED, NO ADDITIONAL INFO WAS PROVIDED.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | XIENCE V EVEROLIMUS ELUTING CORONARY STENT SYSTEM | NIQ | ABBOTT VASCULAR-CARDIAC THERAPIES | NA | 8051361 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 62 YR | Hospitalization| R| S | VESSEL CLOSURE: MANUAL COMPRESSION |